NCT03737994 2026-03-18Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung CancerNational Cancer Institute (NCI)Phase 2 Active not recruiting10 enrolled 17 charts